Highlights from the 5th Annual CNTN Research Symposium

The 5th annual Canadian Nephrology Trials Network (CNTN) Research Symposium took place on May 10, 2023, bringing together patients, providers, and researchers in a celebratory gathering. The event, held at the Canadian Society of Nephrology AGM, served as a platform to honour the achievements of CNTN and explore its future trajectory, while also presenting opportunities for engagement.

This half-day symposium showcased a diverse range of educational presentations by esteemed kidney researchers. These researchers, through their diligent efforts, are making significant contributions to our understanding and treatment of kidney disease.  


Presentations included:

Dr. Bhanu Prasad: Decoding loin pain hematuria syndrome (View video)
Dr. Prasad presented his ongoing research on loin pain hematuria syndrome. His team’s recent work includes phenotype analysis and pedigree chartings in LPHS as well as genomics. His website, www.prasadbhanu.com, has more information on his research program.

Dr. Amélie Bernier-Jean: Evidence for Potassium restriction in hemodialysis (EvoKe-HD) pilot (View video)
“EvoKe-HD is a pilot randomized controlled trial to assess the feasibility and potential for efficacy of a novel dietary approach to hyperkalemia. Contrary to the traditional recommendations limiting the intake of high-potassium whole foods, such as fruits and vegetables, we propose to switch the focus to foods containing potassium that is readily absorbed by the body (high bioavailability), such as potassium from additives, processed meats, milk, fruit juices and sugary drinks.”

Dr. Adeera Levin: New investigator-initiated trial 

Dr. Levin presented an upcoming investigator-initiated trial of an investigational drug that will be starting early next year.  


Dr. Morteza Ahmadi: Qidni labs innovative dialysis machine
Dr. Ahmadi presented Qidni Lab’s nearly waterless and portable dialysis machine currently conducting first-in-human dialysis sessions. Able to run on rechargeable batteries with remote, cloud-based monitoring, this machine could provide dialysis for those living in rural or remote areas or who have no or limited access to dialysis. For more information on their trial and device, visit www.qidni.life